Valentina F.
- Country
- Italy
- Department
- Oncology
Research Overview
- Phase II Randomized Trial of Modified FOLFIRINOX and FOLFOX Regimens in Locally Advanced or Metastatic Small Bowel Adenocarcinoma
- Phase II Study of Circulating Tumor DNA-Guided Encorafenib and Cetuximab Retreatment in BRAF V600E Mutated Metastatic Colorectal Cancer Patients
- Phase II Evaluation of 5-Fluorouracil, Panitumumab, and Sotorasib in First-Line Treatment of Advanced KRAS G12C Mutated Colorectal Adenocarcinoma
Data & Insights
Has run more than one trial at 45 of 155 partner sites.
Specializations
Colorectal Cancer Treatment
This investigator specializes in treating advanced colorectal cancer, with particular emphasis on innovative targeted therapies for patients with specific genetic mutations.
- BRAF V600E mutated metastatic colorectal cancer
- KRAS G12C mutated colorectal adenocarcinoma
Research activities focus on developing treatment strategies for patients with specific molecular profiles.
Precision Medicine
The investigator works with targeted therapeutic approaches based on specific genetic mutations and biomarkers in colorectal cancer.
- Circulating tumor DNA (ctDNA) guided therapy
- EGFR blockade treatments
- KRAS inhibitor therapeutics
Expertise includes molecular profiling and personalized treatment selection.
Treatment Innovation
Focus on developing novel combination therapies for colorectal cancer patients with specific molecular characteristics.
- Combined targeted therapy approaches
- Alternative treatment strategies for chemotherapy-ineligible patients
- Biomarker-driven treatment selection
Research encompasses innovative treatment combinations and targeted therapeutic strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.